The price band for the IPO is Rs 68 to Rs 72 per share, and investors can bid for a minimum lot size of 1,600 shares.
Ahead of the IPO, the company has raised Rs 7.68 crore from anchor investors by allocating 10.67 lakh shares on June 19.
The issue has been structured with 47.42% reserved for qualified institutional buyers (QIBs), 14.29% for non-institutional investors (NIIs), and 33.26% for retail investors. Indorient Financial Services is acting as the book-running lead manager, while Bigshare Services is the registrar to the issue. Alacrity Securities is the designated market maker.
Founded in 2013, Aakaar Medical Technologies operates in the medical aesthetics space, supplying dermatology and cosmetic products to physicians, surgeons, and cosmetologists. Its product mix includes skin care, hair care, injectables, laser and aesthetic devices, and home-use products, including solutions for hair loss and pigmentation.
The company distributes both domestically manufactured and imported products from countries like South Korea, Spain, Italy, and Austria, with a presence in over 15 Indian states. It has a dedicated team of 90 sales and service professionals.Financially, Aakaar reported a 33% increase in revenue to Rs 61.76 crore and 110% jump in net profit to Rs 6.04 crore in FY25. The IPO proceeds will be used primarily to meet working capital requirements and for general corporate purposes.
By
